Robert John AVERSA

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CDK2 degraders and uses thereof
- Patent number 12,097,261
- Issue date Sep 24, 2024
- KYMERA THERAPEUTICS, INC.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biaryl amide compounds as kinase inhibitors
- Patent number 10,709,712
- Issue date Jul 14, 2020
- Novartis AG
- Robert John Aversa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds and compositions as kinase inhibitors
- Patent number 10,377,770
- Issue date Aug 13, 2019
- Novartis AG
- Robert John Aversa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biaryl amide compounds as kinase inhibitors
- Patent number 10,245,267
- Issue date Apr 2, 2019
- Novartis AG
- Robert John Aversa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions as RAF kinase inhibitors
- Patent number 10,167,279
- Issue date Jan 1, 2019
- Novartis AG
- Robert John Aversa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biaryl amide compounds as kinase inhibitors
- Patent number 9,694,016
- Issue date Jul 4, 2017
- Novartis AG
- Robert John Aversa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CDK2 INHIBITORS AND USES THEREOF
- Publication number 20240174665
- Publication date May 30, 2024
- Kymera Therapeutics, Inc.
- Philip COLLIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK2 DEGRADERS AND USES THEREOF
- Publication number 20240173419
- Publication date May 30, 2024
- Kymera Therapeutics, Inc.
- Philip COLLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS
- Publication number 20190175606
- Publication date Jun 13, 2019
- Novartis AG
- Robert John AVERSA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
- Publication number 20180362542
- Publication date Dec 20, 2018
- Novartis AG
- Robert John AVERSA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS
- Publication number 20180170917
- Publication date Jun 21, 2018
- Novartis AG
- Robert John AVERSA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS
- Publication number 20170260207
- Publication date Sep 14, 2017
- Novartis AG
- Robert John AVERSA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS
- Publication number 20160038504
- Publication date Feb 11, 2016
- Novartis AG
- Robert John AVERSA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert John AVERSA

Person

Patents Grantslast 30 patents

CDK2 degraders and uses thereof

Biaryl amide compounds as kinase inhibitors

Tricyclic compounds and compositions as kinase inhibitors

Biaryl amide compounds as kinase inhibitors

Compounds and compositions as RAF kinase inhibitors

Biaryl amide compounds as kinase inhibitors

Patents Applicationslast 30 patents

CDK2 INHIBITORS AND USES THEREOF

CDK2 DEGRADERS AND USES THEREOF

BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS

TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS

BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS